Price $328.58 |
Market Cap
19.75B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.1
|
P/B
51.99
|
P/S
6.8
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
34.3
|
Op. Cash Flow
726.8K
|
FCF
9.3
|
|
Op. Margin
29.50%
|
Net Margin
24.60%
|
ROE
215.80%
|
ROI
37.60%
|
|
ROA
22.80%
|
EPS Growth
16.20%
|
Current Ratio
2.4
|
Debt/Equity
411.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $0.37 | - | - | 124.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.07 | - | - | 38.2M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.65 | - | - | 22.7M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.25 | - | - | 59.7M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $3.40 | - | - | 14.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
